Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

Real-Time Planning for Ultrasound-Guided Brachytherapy with Data Analysis Tool Designed to Reduce Clutter

By Medimaging International staff writers
Posted on 04 Dec 2013
To support real-time planning for ultrasound-guided brachytherapy, a new application’s modular design reports the angular and linear position intraoperatively direct to the manufacturer’s treatment planning software. Through direct communication, the new device offers rapid connection for data analysis and reduces disorder in the surgical suite.

Civco Medical Solutions (Coralville, IA, USA) furthers real-time planning capabilities with US Food and Drug Administration (FDA) 510(k) clearance of the EX3 Stepper for low dose rate (LDR) and high dose rate (HDR) ultrasound-guided brachytherapy for prostate cancer detection and treatment. The unique design of the stepper also features a removable electronic unit, which mitigates the risk of damaging transmission components and reduces cleaning time after the procedure.

LDR prostate brachytherapy involves internal radiotherapy where tiny radioactive “seeds” are delivered through a needle and are permanently placed into or near the tumor for treatment. HDR prostate brachytherapy is a similar internal treatment that involves the temporary placement of a tiny radioactive source directly into the tumor or near the targeted treatment area.

Civco’s EX3 Stepper, similar to its predecessor the EXII, provides compatibility for BK Medical, GE Healthcare, Hitachi Aloka, and Siemens transrectal ultrasound probes and it is currently validated for use with Varian Vitesse and VariSeed treatment-planning software.
In addition to receiving FDA 510(k) clearance, CIVCO has also CE Marked the EX3 for sale in the European Union and other countries where the CE Mark is recognized.

Related Links:

Civco Medical Solutions



RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Software Designed for the Assessment of Orthopedic Implant Fixation and Bone Segment Motion

Model-based roentgen stereophotogrammetric analysis (MBRSA) software has been developed for evaluation of orthopedic implant fixation and bone segment motion. The software is the first to measure the in vivo three-dimensional (3D) position and/or relative motion of metal implants, markers beads, and/or bone segments in... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.